1-methyltryptophan has been researched along with Lung Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, F; Kuang, C; Li, X; Li, Y; Yan, J; Yang, Q; Yang, S; Yang, Y | 1 |
| Schmidt, C | 1 |
| Abu Eid, R; Ahmad, S; Berrong, Z; Hammond, S; Janik, JE; Khleif, SN; Matevosyan, A; Mkrtichyan, M; Mohamed, E; Okoev, G; Shrimali, R; Webb, M | 1 |
3 other study(ies) available for 1-methyltryptophan and Lung Neoplasms
| Article | Year |
|---|---|
Discovery of tryptanthrin derivatives as potent inhibitors of indoleamine 2,3-dioxygenase with therapeutic activity in Lewis lung cancer (LLC) tumor-bearing mice.
Topics: Animals; Antineoplastic Agents; Carcinoma, Lewis Lung; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Lung Neoplasms; Mice; Molecular Structure; Quinazolines; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2013 |
The benefits of immunotherapy combinations.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; B7-H1 Antigen; Biomarkers, Tumor; Cancer Vaccines; Cell Cycle Checkpoints; Clinical Trials as Topic; Combined Modality Therapy; CTLA-4 Antigen; Drug Costs; Humans; Immunotherapy; Indoleamine-Pyrrole 2,3,-Dioxygenase; Ipilimumab; Lung Neoplasms; Male; Melanoma; Nivolumab; Oncolytic Virotherapy; Patient Selection; Precision Medicine; Programmed Cell Death 1 Receptor; Survival Analysis; T-Lymphocytes; Tryptophan; Tumor Escape | 2017 |
Antigen-Specific Antitumor Responses Induced by OX40 Agonist Are Enhanced by the IDO Inhibitor Indoximod.
Topics: Animals; Antigens, Differentiation; Cancer Vaccines; Epitopes, T-Lymphocyte; Female; Humans; Immunotherapy; Lung Neoplasms; Mice; Mice, Inbred C57BL; Tryptophan; Tryptophan Oxygenase; Xenograft Model Antitumor Assays | 2018 |